Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy
✍ Scribed by Malcolm Semple; Clive Loveday; Ian Weller; Richard Tedder
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 680 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cell‐free human immunodeficiency virus type‐I (HIV‐1) was precipitated from archival serum with polyethylene glycol (PEG), and HIV‐1 RNA was detected and quantified by reverse transcription and amplification in a nested polymerase chain reaction (PCR). The assay of endpoint dilutions cDNA in nested PCRs allowed an estimation of the minimum RNA copies per unit volume of serum. RNA titres correlated with the classification of HIV‐1 infection by CDC disease groups (30 patients). The geometric mean titres of HIV‐1 serum RNA from patients grouped by disease stage gave minimum estimates of 340 and 400 virions per millilitre of serum in CDC groups II and Ill (n = 6 and 10, respectively) and 4,240 virions per millilitre in CDC group IV (n = 14). An overall fall in viral titre measured in this way was observed in 3 patients during zidovudine treatment. HIV‐1 titres increased in a further 4 patients when therapy was interrupted, stopped, or complicated by secondary infection.
📜 SIMILAR VOLUMES
Baseline genotype resistance analysis was carried out in 48 adults with primary HIV-1 infection between 1995 and 1998 before starting early combination therapy. Seventeen percent (8/48) of the isolates displayed key mutations conferring resistance to reverse transcriptase (RT) inhibitors such as ami
## AMAs are detectable by indirect immunofluorescence (IF) We examined the clinical usefulness of measurements on tissue substrates in 93% to 99% of patients with PBC, but of antimitochondrial autoantibodies (AMA) in prethis method also detects AMAs of differing specificities in dicting disease pr
## Abstract Viral tropism plays an important role in HIV pathogenesis. However, its correlation with the clinical outcome and following exposure to antiretroviral drugs are still unclear. HIV‐1 co‐receptor usage was examined in 206 infected individuals: 67 seroconverters, 52 chronically drug‐naïve,